- Bank of America Stock Stands to Gain on Stress Test and Earnings (Barron’s)
- Fed Officials Project No Rate Increases Through 2022 (Wall Street Journal)
- Bank of America’s top equity strategist is looking for these signals to get more bullish on stocks (MarketWatch)
- Davey the Day Trader Deconstructed (Wall Street Journal)
- Exclusive: Pershing Square’s Ackman eyes $1 billion-plus ‘blank-check’ company – sources (Reuters)
- Suburban housing is a seller’s market now: Real estate agent (Fox Business)
- Regeneron (REGN) announced initiation of first clinical trial of REGN-COV2, dual antibody cocktail for prevention and treatment of COVID-19 (Street Insider)
- This Exclusive Dataset Shows Why Investor Optimism Is Surging (Institutional Investor)
- Moderna Will Start Testing Vaccine on 30,000 People in July (Barron’s)
- Jay Powell delivers dovish message to financial markets (Financial Times)
- Mnuchin Backs More Aid to Hard-Hit Small Businesses (Wall Street Journal)
- $130 Billion in Small-Business Aid Still Hasn’t Been Used (New York Times)
- Pessimistic Pros Missed the Big Rally, and So Did Many Americans (Bloomberg)
- Johnson & Johnson To Start Coronavirus Vaccine Human Trials Ahead Of Schedule In July (Benzinga)
- Here are the biggest stock-market bets among institutional and retail investors, ranked MarketWatch)